In locally advanced BC patients treated with NC, the content of Tumor Infiltrating Lymphocytes (TILs) in the primary biopsy was shown to predict pCR [3, 4], especially in the TN and HER2-positive subsets [5, 6]. Here, ERBB2 is linked to neoplasm.